For over 45 years, Steve Gorlin has been building companies primarily in the biotech and pharma industries. He invests and works with the founders & innovators setting up management, building the operations and bringing in blue chip investors. Mr. Gorlin, with his leadership team, has developed a proprietary methodology for start-up companies, which ensures company success by increasing its market value and creating a high rate of return for investors through an exit via an IPO or private sale.
Gorlin Companies is a healthcare focused Single Family Office specializing in building innovative companies that improve patient quality of care and healthcare economics globally. The company invests across the biotech and pharma sectors at all stages of development, with an emphasis on U.S. based companies that have immediate potential in international markets.
Gorlin Companies has the participation of a wide range of experts in both healthcare and venture investing. Drawing from deal sourcing, legal, fund raising, operational, and due diligence experiences across the healthcare landscape, Gorlin Companies has created a style and a proven track record of investments with high growth potential.
